Retinal phenotyping is a crucial step toward the design of a prospective natural history study, and of paramount importance for the feasibility and the success of any upcoming therapeutic clinical trial in KCNV2-retinopathy, as well as identifying clinically meaningful and reliable structural endpoints. The gene discussed is KCNV2; the disease is retinal disorder.